Income Statement

Q32 BIO INC.

QTTB
Performance Overview Click any row in the table to add it to this chart
in millions USD
Metric Dec 31, 2025 2025 FY Dec 31, 2024 2024 FY Dec 31, 2023 2023 FY Dec 31, 2022 2022 FY Dec 31, 2021 2021 FY Dec 31, 2020 2020 FY Dec 31, 2019 2019 FY Dec 31, 2018 2018 FY
Revenue
53.74 0.00 1.20 3.21 33.97 2.70 1.70 3.70
Cost of Revenue
- - - - - - - -
Gross Profit
53.74 - 1.20 3.21 33.97 2.70 1.70 3.70
Operating Expenses
36.84 66.10 102.59 136.49 129.92 132.97 111.61 65.25
Research & Development
19.16 48.14 62.00 98.35 93.09 100.39 89.40 47.95
Selling, General & Administrative
17.68 17.96 31.26 38.14 36.84 32.57 22.21 17.30
Other Operating Expenses
- - - - - - - -
Operating Income
16.90 -66.10 -101.39 -133.28 -95.95 -130.26 -109.91 -61.55
Non-Operating Income
12.92 20.02 -14.31 -134.48 - - - -
Interest Income
- - - - - - - -
Interest Expense
1.10 1.10 - - - - - -
Other Non-Op Income / Expense
0.00 4.13 14.35 134.48 0.19 1.57 6.03 4.35
Income Before Tax
29.82 -46.09 -87.08 1.20 - - - -
Income Tax Expense
0.00 1.65 25.88 6.20 - - - -
Non-Controlling Interest
- - - - - - - -
Net Income
29.82 -47.73 -112.96 -5.01 -95.76 -128.69 -103.92 -57.22
Supplemental Per share data, derived & other items — not part of the income statement
in millions USD unless noted
Metric Dec 31, 2025 2025 FY Dec 31, 2024 2024 FY Dec 31, 2023 2023 FY Dec 31, 2022 2022 FY Dec 31, 2021 2021 FY Dec 31, 2020 2020 FY Dec 31, 2019 2019 FY Dec 31, 2018 2018 FY
Depreciation & Amortization
- - - - - - - -
EBITDA
16.90 -66.10 -101.39 -133.28 -95.95 -130.26 -109.91 -61.55
Earnings Per Share (Basic)
2.42 -5.12 -1.95 -0.09 - - - -
Diluted EPS
2.42 -6.58 -1.95 -0.09 - - - -
Weighted Average Shares
12.30 9.32 57.83 57.40 - - - -
Diluted Weighted Avg Shares
12.31 9.66 57.83 57.40 - - - -
Comprehensive Income
29.82 -47.73 -112.56 -5.40 -95.77 -128.88 -103.66 -57.22